Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Elia Malek, Helen Ismail, Hassan Doumiati & Johnny Salameh. (2020) Characteristics of amyotrophic lateral sclerosis in Lebanon-a chart review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 614-619.
Read now
Read now
Pamela A. McCombe, Fleur C Garton, Matthew Katz, Naomi R Wray & Robert D Henderson. (2020) What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?. Expert Review of Neurotherapeutics 20:9, pages 921-941.
Read now
Read now
So Young Pyun, Yerim Kim, Seong-Il Oh & Jong Seok Bae. (2020) Differences in nerve excitability properties between isolated bulbar palsy and bulbar-dominant amyotrophic lateral sclerosis. Neurological Research 42:2, pages 133-140.
Read now
Read now
C. Flaherty, J. Kraft, A. Brothers, M. Harrison, R.S. Legro, A. Manni, C. Yang & Z. Simmons. (2017) The relationship between oestrogen and executive functioning in ALS females with emerging Frontotemporal Lobar Degeneration (FTLD) supports a neuroendocrine model of FTLD attenuation. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:1-2, pages 74-85.
Read now
Read now
Lisa A. van der Kleij, Ashley R. Jones, I Nick Steen, Carolyn A. Young, Pamela J. Shaw, Christopher E. Shaw, P. Nigel Leigh, Martin R. Turner & Ammar Al-Chalabi. (2015) Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:7-8, pages 442-447.
Read now
Read now
Betul Gundogdu, Tawfiq Al-Lahham, Fred Kadlubar, Horace Spencer & Stacy A. Rudnicki. (2014) Racial differences in motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:1-2, pages 114-118.
Read now
Read now
James R. Burrell, Steve Vucic & Matthew C. Kiernan. (2012) Response to Karam et al.. Amyotrophic Lateral Sclerosis 13:1, pages 159-160.
Read now
Read now
Chafic Karam. (2012) IBP is a form of PLS and should be distinguished from PBP. Amyotrophic Lateral Sclerosis 13:1, pages 158-158.
Read now
Read now
Articles from other publishers (42)
Manisha Chavan, Ajay Singh, Pinank K Bathvar, Sarang T Mehta, Abdul K Qadree & Sandesh Dhakal. (2023) Bulbar onset amyotrophic lateral sclerosis with more evident symptoms in the left hemibody: a case report. Oxford Medical Case Reports 2023:5.
Crossref
Crossref
Alessio Maranzano, Federico Verde, Eleonora Colombo, Barbara Poletti, Alberto Doretti, Ruggero Bonetti, Delia Gagliardi, Megi Meneri, Luca Maderna, Stefano Messina, Stefania Corti, Claudia Morelli, Vincenzo Silani & Nicola Ticozzi. (2023) Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis. Brain.
Crossref
Crossref
J.A. Membrilla. (2023) Varón de 55 años con debilidad y atrofia en miembro superior izquierdo de 6 meses de evolución. Medicine - Programa de Formación Médica Continuada Acreditado 13:75, pages 4479.e1-4479.e3.
Crossref
Crossref
Michele Barone & Isabella Laura Simone. 2023. Diet and Nutrition in Neurological Disorders. Diet and Nutrition in Neurological Disorders
141
153
.
Zhengqing He, Bo Sun, Feng Feng, Jiongming Bai, Haoran Wang, Hongfen Wang, Fei Yang, Fang Cui & Xusheng Huang. (2021) Time of symptoms beyond the bulbar region predicts survival in bulbar onset amyotrophic lateral sclerosis. Neurological Sciences 43:3, pages 1817-1822.
Crossref
Crossref
Amy Lawton & Maja Husaric. 2022. Exercise to Prevent and Manage Chronic Disease Across the Lifespan. Exercise to Prevent and Manage Chronic Disease Across the Lifespan
349
361
.
Huagang Zhang, Lu Chen, Jinzhou Tian & Dongsheng Fan. (2021) Disease duration of progression is helpful in identifying isolated bulbar palsy of amyotrophic lateral sclerosis. BMC Neurology 21:1.
Crossref
Crossref
Zhen Liu, Yanchun Yuan, Mengli Wang, Jie Ni, Wanzhen Li, Ling Huang, Yiting Hu, Pan Liu, Xiaorong Hou, Xuan Hou, Juan Du, Ling Weng, Ruxu Zhang, Qi Niu, Jianguang Tang, Hong Jiang, Lu Shen, Beisha Tang & Junling Wang. (2021) Mutation spectrum of amyotrophic lateral sclerosis in Central South China. Neurobiology of Aging 107, pages 181-188.
Crossref
Crossref
Sarah K. Bublitz, Christiane Weck, Andrea Egger-Rainer, Katharina Lex, Piret Paal & Stefan Lorenzl. (2021) Palliative Care Challenges of Patients With Progressive Bulbar Palsy: A Retrospective Case Series of 14 Patients. Frontiers in Neurology 12.
Crossref
Crossref
Nikol Jankovska & Radoslav Matej. (2021) Molecular Pathology of ALS: What We Currently Know and What Important Information Is Still Missing. Diagnostics 11:8, pages 1365.
Crossref
Crossref
Thanuja Dharmadasa. (2021) Cortical Excitability across the ALS Clinical Motor Phenotypes. Brain Sciences 11:6, pages 715.
Crossref
Crossref
M.-D.-M. Amador, F. Muratet, E. Teyssou, S. Boillée & S. Millecamps. (2021) New advances in Amyotrophic Lateral Sclerosis genetics: Towards gene therapy opportunities for familial and young cases. Revue Neurologique 177:5, pages 524-535.
Crossref
Crossref
Huiyan Yu, Lu Chen, Shuo Zhang, Jing He & Dongsheng Fan. (2021) Early Axonal Dysfunction of the Peripheral Nervous System Influences Disease Progression of ALS: Evidence From Clinical Neuroelectrophysiology. Frontiers in Neurology 12.
Crossref
Crossref
Ben Hadad & Boaz Lerner. (2020) Domain adaptation from clinical trials data to the tertiary care clinic – Application to ALS. Domain adaptation from clinical trials data to the tertiary care clinic – Application to ALS.
Colin Quinn & Lauren Elman. (2020) Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases. CONTINUUM: Lifelong Learning in Neurology 26:5, pages 1323-1347.
Crossref
Crossref
Mana Higashihara, Mehdi A.J. Van den Bos, Parvathi Menon, Matthew C. Kiernan & Steve Vucic. (2020) Interneuronal networks mediate cortical inhibition and facilitation. Clinical Neurophysiology 131:5, pages 1000-1010.
Crossref
Crossref
W.B.V.R. Pinto, R. Debona, P.P. Nunes, A.C.D. Assis, C.G. Lopes, T. Bortholin, R.B. Dias, F.G.M. Naylor, M.A.T. Chieia, P.V.S. Souza & A.S.B. Oliveira. (2019) Atypical Motor Neuron Disease variants: Still a diagnostic challenge in Neurology. Revue Neurologique 175:4, pages 221-232.
Crossref
Crossref
Hans-Peter Müller, Martin Gorges, Kelly Del Tredici, Albert C. Ludolph & Jan Kassubek. (2019) The same cortico-efferent tract involvement in progressive bulbar palsy and in ‘classical’ ALS: A tract of interest-based MRI study. NeuroImage: Clinical 24, pages 101979.
Crossref
Crossref
Ileana M. Howard & Nassim Rad. (2018) Electrodiagnostic Testing for the Diagnosis and Management of Amyotrophic Lateral Sclerosis. Physical Medicine and Rehabilitation Clinics of North America 29:4, pages 669-680.
Crossref
Crossref
Thanuja Dharmadasa, José Manuel Matamala, William Huynh, Margaret C. Zoing & Matthew C. Kiernan. 2018. Balance, Gait, and Falls. Balance, Gait, and Falls
345
357
.
Hua-Gang Zhang, Lu Chen, Lu Tang, Nan Zhang & Dong-Sheng Fan. (2017) Clinical Features of Isolated Bulbar Palsy of Amyotrophic Lateral Sclerosis in Chinese Population. Chinese Medical Journal 130:15, pages 1768-1772.
Crossref
Crossref
Thanuja Dharmadasa, Robert D Henderson, Paul S Talman, Richard AL Macdonell, Susan Mathers, David W Schultz, Merrillee Needham, Margaret Zoing, Steve Vucic & Matthew C Kiernan. (2017) Motor neurone disease: progress and challenges. Medical Journal of Australia 206:8, pages 357-362.
Crossref
Crossref
Martin R Turner & Kevin Talbot. (2017) Sweet food preference in amyotrophic lateral sclerosis. Practical Neurology 17:2, pages 128-129.
Crossref
Crossref
Gabriela D. Colpo, Fabiola M. Ribeiro, Natalia P. Rocha & Antônio L. Teixeira. 2017. Animal Models for the Study of Human Disease. Animal Models for the Study of Human Disease
1109
1129
.
Ammar Al-Chalabi, Orla Hardiman, Matthew C Kiernan, Adriano Chiò, Benjamin Rix-Brooks & Leonard H van den Berg. (2016) Amyotrophic lateral sclerosis: moving towards a new classification system. The Lancet Neurology 15:11, pages 1182-1194.
Crossref
Crossref
Maartje G. Huijbers, Erik H. Niks, Rinse Klooster, Marianne de Visser, Jan B. Kuks, Jan H. Veldink, Pim Klarenbeek, Philip Van Damme, Marc H. de Baets, Silvère M. van der Maarel, Leonard H. van den Berg & Jan J. Verschuuren. (2016) Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis. Neuromuscular Disorders 26:6, pages 350-353.
Crossref
Crossref
Jeffrey M. Statland, Richard J. Barohn, April L. McVey, Jonathan S. Katz & Mazen M. Dimachkie. (2015) Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis. Neurologic Clinics 33:4, pages 735-748.
Crossref
Crossref
Omar Jawdat, Jeffrey M. Statland, Richard J. Barohn, Jonathan S. Katz & Mazen M. Dimachkie. (2015) Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis). Neurologic Clinics 33:4, pages 775-785.
Crossref
Crossref
Ghanshyam Upadhyay, Sharmila Shankar & Rakesh K. Srivastava. (2014) Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes. Molecular Neurobiology 52:1, pages 610-625.
Crossref
Crossref
Martin R Turner & Michael Swash. (2015) The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey. Journal of Neurology, Neurosurgery & Psychiatry 86:6, pages 667-673.
Crossref
Crossref
Steve Vucic, Jeffrey D. Rothstein & Matthew C. Kiernan. (2014) Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies. Trends in Neurosciences 37:8, pages 433-442.
Crossref
Crossref
Andrew Eisen, Martin R. Turner & Roger Lemon. (2014) Tools and talk: An evolutionary perspective on the functional deficits associated with amyotrophic lateral sclerosis. Muscle & Nerve 49:4, pages 469-477.
Crossref
Crossref
James R. Burrell, Michael Hornberger, Steve Vucic, Matthew C. Kiernan & John R. Hodges. (2014) Apraxia and Motor Dysfunction in Corticobasal Syndrome. PLoS ONE 9:3, pages e92944.
Crossref
Crossref
Parvathi Menon, Matthew C. Kiernan & Steve Vucic. (2014) ALS pathophysiology: Insights from the split-hand phenomenon. Clinical Neurophysiology 125:1, pages 186-193.
Crossref
Crossref
Roisin Lonergan, Hiroshi Mistumoto & Brian Murray. 2014. Neuromuscular Disorders in Clinical Practice. Neuromuscular Disorders in Clinical Practice
395
423
.
Neil G. Simon, Stephen W. Reddel, Matthew C. Kiernan & Robert Layzer. (2013) Muscle-specific kinase antibodies: A novel cause of peripheral nerve hyperexcitability?. Muscle & Nerve 48:5, pages 819-823.
Crossref
Crossref
Martin R Turner & Kevin Talbot. (2013) Mimics and chameleons in motor neurone disease. Practical Neurology 13:3, pages 153-164.
Crossref
Crossref
Martin R Turner, Orla Hardiman, Michael Benatar, Benjamin R Brooks, Adriano Chio, Mamede de Carvalho, Paul G Ince, Cindy Lin, Robert G Miller, Hiroshi Mitsumoto, Garth Nicholson, John Ravits, Pamela J Shaw, Michael Swash, Kevin Talbot, Bryan J Traynor, Leonard H Van den Berg, Jan H Veldink, Steve Vucic & Matthew C Kiernan. (2013) Controversies and priorities in amyotrophic lateral sclerosis. The Lancet Neurology 12:3, pages 310-322.
Crossref
Crossref
Chafic Karam. (2011) IBP is a form of PLS and should be distinguished from PBP. Amyotrophic Lateral Sclerosis, pages 1-1.
Crossref
Crossref
Orla Hardiman, Leonard H. van den Berg & Matthew C. Kiernan. (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nature Reviews Neurology 7:11, pages 639-649.
Crossref
Crossref
James R. Burrell, Con Yiannikas, Dominic Rowe & Matthew C. Kiernan. (2011) Predicting a Positive Response to Intravenous Immunoglobulin in Isolated Lower Motor Neuron Syndromes. PLoS ONE 6:10, pages e27041.
Crossref
Crossref
James R. Burrell, Matthew C. Kiernan, Steve Vucic & John R. Hodges. (2011) Motor Neuron dysfunction in frontotemporal dementia. Brain 134:9, pages 2582-2594.
Crossref
Crossref